v3.25.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses:        
Research and development $ 8,704 $ 5,539 $ 19,178 $ 9,132
General and administrative 9,358 6,220 18,138 11,006
Total operating expenses 18,062 11,759 37,316 20,138
Loss from operations (18,062) (11,759) (37,316) (20,138)
Other (income)/expense, net:        
Interest income (1,717) (2,196) (3,534) (3,411)
Change in fair value of private placement warrants   768   1,374
Other income, net (352) (2) (347) (25)
Total other income, net (2,069) (1,430) (3,881) (2,062)
Loss before income taxes (15,993) (10,329) (33,435) (18,076)
Net loss (15,993) (10,329) (33,435) (18,076)
Accretion of redeemable noncontrolling interest to redemption value   (2,337)   (2,337)
Adjustment of redeemable noncontrolling interest from redemption value to carrying value       7,017
Net loss attributable to Class A Ordinary Shareholders of Zura $ (15,993) $ (12,666) $ (33,435) $ (13,396)
Net loss per share attributable to Class A Ordinary Shareholders of Zura, basic (in dollars per share) $ (0.17) $ (0.17) $ (0.36) $ (0.22)
Net loss per share attributable to Class A Ordinary Shareholders of Zura, diluted (in dollars per share) $ (0.17) $ (0.17) $ (0.36) $ (0.22)
Weighted-average Class A Ordinary Shares used in computing net loss per share attributable to Class A Ordinary Shareholders of Zura, basic (in shares) 94,289,954 74,947,369 93,630,719 60,930,956
Weighted-average Class A Ordinary Shares used in computing net loss per share attributable to Class A Ordinary Shareholders of Zura, diluted (in shares) 94,289,954 74,947,369 93,630,719 60,930,956